{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:41:44Z","timestamp":1753879304187,"version":"3.41.2"},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Treatment of onychomycosis is still challenging and warrants the development of new treatment strategies. Different trials were conducted to increase the penetration and efficacy of topical antifungals aiming at finding an alternative treatment especially when systemic antifungals are contraindicated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To evaluate the efficacy of trichloroacetic acid (TCA) 100% either alone or combined with topical tioconazole 28% versus itraconazole pulse therapy in the treatment of onychomycosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients\/Methods<\/jats:title><jats:p>Forty\u2010five patients with onychomycosis were divided into three groups: group (A) treated by topical TCA 100% for 12 sessions, group (B) treated by TCA 100% for 12 sessions combined with topical tioconazole 28% for 18\u2009weeks and group (C) treated by itraconazole (400\u2009mg\/day for 1 week\/month for 4\u2009months).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>TCA 100% combined with topical tioconazole 28% showed the highest therapeutic response; however, the difference between the groups was statistically insignificant. Mycological cure (negative culture) was reported in 66.7% of group B versus 60% of group A and 40% of group C at the 20 week.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TCA 100% is an effective and safe treatment option for onychomycosis especially when combined with antifungals. This modality is promising in the treatment of onychomycosis especially with the increased resistance to different antifungals.<\/jats:p><\/jats:sec>","DOI":"10.1111\/myc.13690","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T03:19:48Z","timestamp":1704165588000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of topical trichloroacetic acid 100% either alone or combined with topical tioconazole 28% versus systemic itraconazole in the treatment of onychomycosis"],"prefix":"10.1111","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9674-4703","authenticated-orcid":false,"given":"Al\u2010shimaa M.","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Dermatology and Andrology Department, Faculty of Medicine Zagazig University  Zagazig Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermeen Sabry","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Dermatology and Andrology Department, Faculty of Medicine Zagazig University  Zagazig Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman S.","family":"Elgharabawy","sequence":"additional","affiliation":[{"name":"Medical Microbiology and Immunology Department, Faculty of Medicine Zagazig University  Zagazig Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala Mohamed","family":"Morsi","sequence":"additional","affiliation":[{"name":"Dermatology and Andrology Department, Faculty of Medicine Zagazig University  Zagazig Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.730"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.062"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof9050559"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.201700350"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-017-2198-6"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000495152"},{"issue":"2","key":"e_1_2_8_8_1","first-page":"25","article-title":"Efficacy of trichloroacetic acid in patients with toenail onychomycosis: pilot study with 14 patients","volume":"19","author":"Lee WJ","year":"2014","journal-title":"Korean J Med Mycol"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.7241\/ourd.20123.42"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.4103\/jmms.jmms_53_19"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15660"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.148912"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.46.171"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1509046"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-009-9209-5"},{"issue":"3","key":"e_1_2_8_16_1","first-page":"350","article-title":"Frequency of Candida in onychomycosis","volume":"63","author":"Ahmed R","year":"2013","journal-title":"J Pakistan Med Assoc"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.21608\/ejbo.2017.965.1080"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1985.tb00537.x"},{"issue":"1","key":"e_1_2_8_19_1","first-page":"152","article-title":"Evaluation of the antifungal activity of Tazarotene 0.1% gel in comparison to tioconazole 28% solution in treating onychomycosis: a clinical, microbiological and in\u00a0vitro study","volume":"2","author":"Abdelhamid A","year":"2021","journal-title":"Microbes Infect Dis"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13155"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04373.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1829592"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12799"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.18646.1"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16394"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S84765"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000508926"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/myc.13690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T08:54:43Z","timestamp":1707296083000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/myc.13690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1111\/myc.13690"],"URL":"https:\/\/doi.org\/10.1111\/myc.13690","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"type":"print","value":"0933-7407"},{"type":"electronic","value":"1439-0507"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13690"}}